Profile
Rosalind Wilson is currently Chief Medical Officer at Prescient Therapeutics Ltd. since 2026.
Former roles include Chief Executive Officer at Invert Graphite Ltd. from 2017 to 2019 and Non-Executive Director at AdAlta Ltd. from 2019 to 2020.
Education includes a doctorate from Monash University and an MBA from London Business School.
Rosalind Wilson active positions
| Companies | Position | Start |
|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Chief Tech/Sci/R&D Officer | 13/07/2026 |
Former positions of Rosalind Wilson
| Companies | Position | End |
|---|---|---|
| ADALTA LIMITED | Director/Board Member | 27/03/2020 |
| INVERT GRAPHITE LIMITED | Chief Executive Officer | 25/01/2019 |
Training of Rosalind Wilson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Invert Graphite Ltd.
Invert Graphite Ltd. Construction MaterialsNon-Energy Minerals Engages in mining of lime and other minerals | Non-Energy Minerals |
Prescient Therapeutics Ltd.
Prescient Therapeutics Ltd. BiotechnologyHealth Technology Operates as a a clinical stage oncology company | Health Technology |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdAlta Ltd.
AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
- Stock Market
- Insiders
- Rosalind Wilson
















